The epidemiology of progressive intellectual and neurological deterioration in childhood

Christopher Verity1, Anne Marie Winstone, Lesley Stellitano

  • 1PIND Surveillance Group, Child Development Centre, Addenbrooke's Hospital, Cambridge, UK. christopher.verity@addenbrookes.nhs.uk

Insights

This study tracked children with progressive intellectual and neurological deterioration (PIND) in the UK. While many rare diseases were identified, only six cases of variant Creutzfeldt-Jakob disease (vCJD) were found, offering reassurance but also highlighting ongoing concerns.

Area of Science:

  • Pediatric Neurology
  • Epidemiology
  • Neurodegenerative Diseases

Background:

  • Progressive intellectual and neurological deterioration (PIND) encompasses a wide range of rare childhood diseases.
  • Understanding the epidemiology of PIND is crucial for diagnosis and management.
  • Variant Creutzfeldt-Jakob disease (vCJD) is a rare but devastating neurodegenerative condition.

Purpose of the Study:

  • To investigate the epidemiology of diseases causing PIND in children across the United Kingdom.
  • To actively surveil for variant Creutzfeldt-Jakob disease (vCJD) in pediatric populations.

Main Methods:

  • Active surveillance of UK consultant pediatricians via the British Paediatric Surveillance Unit.
  • Data collection through questionnaires and site visits for suspected PIND cases.
  • Independent classification of cases by an Expert Group.

Main Results:

  • Over 12 years, 2636 children under 16 with suspected PIND were reported; 1114 had confirmed diagnoses.
  • Leukoencephalopathies, neuronal ceroid lipofuscinoses, and mitochondrial diseases were common PIND groups.
  • Only six cases of vCJD were identified in children.

Conclusions:

  • The study provides novel epidemiological insights into childhood PIND in the UK.
  • Active surveillance has identified a low incidence of vCJD in children, which is reassuring.
  • Ongoing vigilance for potential future vCJD cases, possibly with different genotypes, is warranted.
Abstract

Related Concept Videos

Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Intellectual Disability01:29

Intellectual Disability

Intellectual disability (ID) is a neurodevelopmental condition characterized by deficits in intellectual and adaptive functioning that manifest during the developmental period. This condition encompasses challenges in reasoning, memory, problem-solving, and learning, accompanied by impairments in everyday life skills, such as communication, self-care, and social interactions. Intellectual disability affects approximately 1% of the population in the United States, impacting an estimated 5...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Disorders of the Nervous Tissue01:28

Disorders of the Nervous Tissue

Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...